InvestorsHub Logo
Followers 113
Posts 25553
Boards Moderated 4
Alias Born 02/01/2004

Re: None

Friday, 04/17/2015 1:04:54 PM

Friday, April 17, 2015 1:04:54 PM

Post# of 6725
Tekmira Pharmaceuticals Upgraded by Vetr Inc. to $30

Posted by Zach Kirkland on Apr 16th, 2015

Tekmira Pharmaceuticals Co. logoVetr upgraded shares of Tekmira Pharmaceuticals (NASDAQ:TKMR) from a buy rating to a strong-buy rating in a research report released on Wednesday morning. Vetr currently has $30.00 price objective on the stock.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABUS News